Synthetic plasma volume expanders--their pharmacology, safety and clinical efficacy.
D000707:Anaphylaxis / Q000139:chemically induced; D001802:Blood Substitutes / Q000627:therapeutic use; D001810:Blood Volume / Q000187:drug effects; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D003451:Cryoprotective Agents; D003911:Dextrans / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005780:Gelatin / Q000097:blood; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000097:blood / Q000494:pharmacology; D007937:Leukapheresis; D046911:Macromolecular Substances; D010952:Plasma Substitutes / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D014018:Tissue Distribution
D001802:Blood Substitutes; D003451:Cryoprotective Agents; D003911:Dextrans; D005343:Fibrinolytic Agents; D006895:Hydroxyethyl Starch Derivatives; D046911:Macromolecular Substances; D010952:Plasma Substitutes; D005780:Gelatin